Pfizer Inc vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Pfizer Inc trades at $24.93 (market cap $142.14B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.68. The key difference: Pfizer Inc pays a 6.9% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals.
| PFE | XDTE | |
|---|---|---|
Market Cap | $142.14B | — |
Volume | 29,869,932 | — |
Sector | Health | Income / Options Overlay |
52-Week High | $28.56 | $44.76 |
52-Week Low | $23.29 | $36.00 |
Enterprise Value | $192.80B | — |
Dividend Yield | 6.9% | — |
Signals from Pluang's Aura AI — not financial advice
Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.
Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.
XDTE trades at $38.44, down 0.1% on the day, with technical indicators showing a bearish trend. The ETF generates frequent dividend payouts but faces scrutiny over sustainability. Recent news highlights concerns about yield calculations and NAV erosion despite high distribution frequency.
The outlook remains cautious due to structural risks in the covered call strategy and declining NAV. Investors face trade-offs between high income potential and capital depreciation risks in volatile markets.
Trailing returns across standard periods
Latest headlines on both assets
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →